Safety and Efficacy of New Oral Anticoagulant Agents What We Know Now
Tracking # 20-629345
Course overview
Goals and Objectives Goals The goal of this article is to summarize the available clinical trial evidence and a proposed approach regarding the safety and efficacy of new oral anticoagulants. Objectives Discuss the safety and efficacy of new oral anticoagulants when compared with Warfarin Discuss the safety and efficacy of new oral coagulants in general Describe the safety and efficacy of Rivaroxaban Identify the two efficacy facets of oral anticoagulant therapy Discuss the safety concerns of NOACs Describe the safety and efficacy of NOACs in Phase III clinical studies
Subject areas
This course counts toward the state boards and subject areas below.
Arkansas State Board of Nursing
Certified Nurse Practitioner
1.8h
Pharmacotherapeutics continuing education in the area of certification
Certified Registered Nurse Anesthetist
1.8h
Pharmacotherapeutics continuing education in the area of certification
Clinical Nurse Specialist
1.8h
Pharmacotherapeutics continuing education in the area of certification
Registered Nurse
2h
Practice-Focused Continuing Education
Registered Nurse Practitioner
2h
Practice-Focused Continuing Education
District of Columbia Board of Nursing
Clinical Nurse Specialist
1.8h
Pharmacology Component
0.2h
Relevant to Clinical Nurse Specialty
Nurse Practitioner
1.8h
Pharmacology Component
0.2h
Relevant to Nurse Practitioner Specialty
Registered Nurse
2h
Registered Nurse District of Columbia - Continuing Education
Registered Nurse Anesthetist
0.2h
Relevant to Registered Nurse Anesthetist Specialty
1.8h
Pharmacology Component
Georgia Board of Nursing
Registered Professional Nurse
2h
General
South Carolina Board of Nursing
Advanced Practice Registered Nurse
1.8h
Pharmacotherapeutics
0.2h
General
Registered Nurse
0.2h
General
1.8h
Pharmacotherapeutics